Article
Somatic FGFR3 Mutations Distinguish a Subgroup of Muscle-Invasive Bladder Cancers with Response to Neoadjuvant Chemotherapy.
EBioMedicine - 1 Sept 2018
Yang Zhao, Zhang Ruiyun, Ge Yunxia, Qin Xuying, Kang Xing, Wang Yue, Zhang Xu, Song Chengli, Quan Xiaofang, Wang Haifeng, Chen Haige, Li Chong
Abstract excerpt
The administration of neoadjuvant chemotherapy (NAC) preceding radical cystectomy benefits overall survival for patients with muscle-invasive bladder cancer (MIBC). However, the relationship between the genetic profiling of MIBC and NAC response remains unclear. Here, a mutation panel of six cancer-associated genes (TSC1, FGFR3, TERT, TP53, PIK3CA and ERBB2) and an immunohistochemistry (IHC) panel containing...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
